ES2059605T3 - Vacuna toxoide de la tosferina. - Google Patents

Vacuna toxoide de la tosferina.

Info

Publication number
ES2059605T3
ES2059605T3 ES89107157T ES89107157T ES2059605T3 ES 2059605 T3 ES2059605 T3 ES 2059605T3 ES 89107157 T ES89107157 T ES 89107157T ES 89107157 T ES89107157 T ES 89107157T ES 2059605 T3 ES2059605 T3 ES 2059605T3
Authority
ES
Spain
Prior art keywords
tospherin
toxoid vaccine
vaccine
toxoid
prevent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89107157T
Other languages
English (en)
Inventor
Larry K Winberry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MASSACHUSETTS HEALTH RES
Original Assignee
MASSACHUSETTS HEALTH RES
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MASSACHUSETTS HEALTH RES filed Critical MASSACHUSETTS HEALTH RES
Application granted granted Critical
Publication of ES2059605T3 publication Critical patent/ES2059605T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Abstract

UNA TOXINA IMMUNOGENICA ESTABLE APROPIADA COMO UNA VACUNA PARA PREVENIR.
ES89107157T 1988-04-20 1989-04-20 Vacuna toxoide de la tosferina. Expired - Lifetime ES2059605T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18388488A 1988-04-20 1988-04-20

Publications (1)

Publication Number Publication Date
ES2059605T3 true ES2059605T3 (es) 1994-11-16

Family

ID=22674711

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89107157T Expired - Lifetime ES2059605T3 (es) 1988-04-20 1989-04-20 Vacuna toxoide de la tosferina.

Country Status (10)

Country Link
US (1) US5989564A (es)
EP (1) EP0338566B1 (es)
JP (1) JP2889923B2 (es)
AT (1) ATE110964T1 (es)
AU (1) AU631351B2 (es)
DE (1) DE68917972T2 (es)
DK (1) DK192489A (es)
ES (1) ES2059605T3 (es)
YU (1) YU47972B (es)
ZA (1) ZA892908B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5453272A (en) * 1992-10-02 1995-09-26 Alberta Research Council Lectin derived carbohydrate binding-peptide
WO1994007517A1 (en) * 1992-10-02 1994-04-14 Alberta Research Council Anti-inflammatory tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides
US5856122A (en) * 1993-08-24 1999-01-05 University Of Alberta Modification of pertussis toxin
WO2021001540A1 (en) 2019-07-04 2021-01-07 Proxi Biotech Aps Detoxification of proteins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8512972D0 (en) * 1985-05-22 1985-06-26 Univ Glasgow Vaccine production
US4762710A (en) * 1986-06-16 1988-08-09 The United States Of America As Represented By The Department Of Health And Human Services Novel method of preparing toxoid by oxidation and metal ions

Also Published As

Publication number Publication date
EP0338566A2 (en) 1989-10-25
JPH0272200A (ja) 1990-03-12
AU631351B2 (en) 1992-11-26
ATE110964T1 (de) 1994-09-15
US5989564A (en) 1999-11-23
ZA892908B (en) 1990-04-25
DK192489A (da) 1989-10-21
AU3318289A (en) 1989-10-26
EP0338566A3 (en) 1990-08-22
YU80389A (en) 1992-05-28
JP2889923B2 (ja) 1999-05-10
DK192489D0 (da) 1989-04-20
YU47972B (sh) 1996-08-13
DE68917972T2 (de) 1995-01-05
DE68917972D1 (de) 1994-10-13
EP0338566B1 (en) 1994-09-07

Similar Documents

Publication Publication Date Title
GR890100838A (el) Νέα ?εραπευτικώς δραστική ένωσις και μέ?οδος για την παραγωγή της.
ATE121947T1 (de) Verbessertes meningokokkale polysaccharidkonjugatvakzin.
ATE188508T1 (de) Impfstoffe gegen diphtherietoxin
FR2629717B1 (fr) Preparation de vaccin
ES550152A0 (es) Conjugados estables de polisacarido-proteina
ES2140076T3 (es) Vacunas que contienen una saponina y un esterol.
ES2029905T3 (es) Implantacion para fijar protesis dental.
ES2024053B3 (es) Un dispositivo para fijar una protesis dental.
ES2044849T3 (es) Un procedimiento para preparar un glicosido de flavona.
ATE43968T1 (de) Hapten- und muramylpeptidkonjugate, mit immunogenischer wirksamkeit und die selben enthaltende zubereitungen.
FI891283A0 (fi) Ifosfamid-mesna-lyofilisat och foerfarande foer dess framstaellning.
DK1024824T3 (da) Dispergerende vaccinesammensætning i fast form til oral indgivelse
NO972219D0 (no) Immunogenpreparater
ES2079438T5 (es) Lubricante esterilizable.
ES2059605T3 (es) Vacuna toxoide de la tosferina.
ES538474A0 (es) Un procedimiento para preparar una vacuna capaz de inducir inmunidad a la moraxella bovis.
ES2019634B3 (es) Terapia con clorfeniramina.
NO892997D0 (no) Bordetella pertussis vaksine.
ES2166763T3 (es) Inmunizacion parenteral contra rotavirus.
AU561683B2 (en) Combined influenza, diphtheria, tetanus vaccine
ES2082221T3 (es) Neuraminidasa y galactosa-oxidasa en calidad de adyuvante de vacunas.
SE8204871D0 (sv) Farmaceutiska preparat, innefattande humant proinsulin
FI894072A0 (fi) Polypeptider anvaendbara som vaccin.
MX9206135A (es) Metodos
SE8705035L (sv) Anvaendning av alkylglycerol

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 338566

Country of ref document: ES